Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Embryonic stem cells for cardiac muscle engineering.

Wolfram-Hubertus Zimmermann1, Thomas Eschenhagen

  • 1Institute of Experimental and Clinical Pharmacology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. w.zimmermann@uke.uni-hamburg.de

Trends in Cardiovascular Medicine
|May 8, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human-induced pluripotent stem cell cardiomyocytes for risk stratification of patients with LQT syndrome-ready for practice?

Cardiovascular research·2026
Same author

Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart Failure.

The New England journal of medicine·2026
Same author

Mechanical load inhibits cancer growth in mouse and human hearts.

Science (New York, N.Y.)·2026
Same author

Targeting Interleukin-8-Mediated Cellular Crosstalk Reverses Hypertrophic Cardiomyopathy and Cardiac Fibrosis in Noonan Syndrome.

Circulation·2026
Same author

Models of the human heart for biomedical research: Opportunities and challenges.

Physiological reports·2026
Same author

Simtuzumab Attenuates Loxl2-Mediated Extracellular Matrix Remodeling and Preserves Cardiac Function in <i>LMNA</i> Mutation-Induced Dilated Cardiomyopathy.

Circulation. Heart failure·2026

Embryonic stem cells offer a renewable source for cardiac tissue engineering, addressing limitations of current cell sources. This review explores their use and embryo-sparing derivation methods for regenerative medicine.

Area of Science:

  • Regenerative Medicine
  • Biotechnology
  • Cardiovascular Research

Background:

  • Cardiac tissue engineering aims to restore heart function and create platforms for drug testing.
  • Current methods using primary heart cells are limited by their postmitotic nature, hindering clinical and large-scale applications.
  • A renewable cell source is crucial for advancing cardiac tissue engineering.

Purpose of the Study:

  • To review the potential of embryonic stem (ES) cells in cardiac tissue engineering.
  • To discuss alternative, embryo-sparing technologies for generating ES cell lines.
  • To highlight the need for scalable and clinically applicable cell sources.

Main Methods:

  • Literature review of current research in cardiac tissue engineering and stem cell biology.

Related Experiment Videos

  • Analysis of the properties and differentiation capacity of embryonic stem cells for cardiac applications.
  • Evaluation of embryo-sparing methods for ES cell derivation.

    • Main Results:

    • Embryonic stem cells are a promising renewable source due to their proliferative capacity and differentiation potential into cardiomyocytes.
    • Traditional ES cell isolation destroys embryos, necessitating alternative derivation strategies.
    • Embryo-sparing technologies offer a path towards ethical and scalable ES cell production.

    Conclusions:

    • Embryonic stem cells hold significant promise for cardiac tissue engineering and regenerative medicine.
    • Development of embryo-sparing derivation techniques is essential for widespread clinical and research applications.
    • Further research is needed to optimize ES cell differentiation and integration for functional cardiac tissues.